Table 1.

Details of the study population (21 cases of postcardiotomy extracorporeal membrane oxygenation)

Case	Age	Weight (kg)	ECMO implant site	CPB duration (minutes)	ECMO duration (hours)	Thrombotic complications	Anticoagulant	Outcome
1	Adult	105	OR	498	50	None	Heparin	Dead on ECMO
2	Adult	66	OR	322	170	None	Heparin	Dead on ECMO
3	Adult	100	OR	118	40	None	Heparin	Survived
4	Infant	2.9	OR	115	124	None	Heparin	Dead on ECMO
5	Child	15	OR	74	40	None	Heparin	Survived
6	Infant	3.6	ICU	125	110	None	Heparin	Weaned and dead
7	Newborn	2.7	OR	273	90	None	Heparin	Dead on ECMO
8	Newborn	3	ICU	317	16	None	Heparin	Dead on ECMO
9	Child	45	ICU	150	234	None	Bivalirudin	Dead on ECMO
10	Adult	60	ICU	73	88	None	Bivalirudin	Weaned and dead
11	Adult	74	OR	221	135	None	Bivalirudin	Survived
12	Adult	95	OR	180	39	None	Bivalirudin	Dead on ECMO
13	Adult	76	ICU	345	262	None	Bivalirudin	Weaned and dead
14	Adult	85	OR	198	233	None	Bivalirudin	Dead on ECMO
15	Adult	65	OR	442	69	None	Bivalirudin	Survived
16	Adult	75	OR	402	190	None	Bivalirudin	Weaned and dead
17	Adult	65	OR	315	67	None	Bivalirudin	Weaned and dead
18	Infant	7	ICU	85	175	None	Bivalirudin	Weaned and dead
19	Newborn	3.3	OR	255	110	None	Bivalirudin	Survived
20	Infant	7.6	OR	266	168	Yes	Bivalirudin	Weaned and dead
21	Newborn	2.6	OR	559	87	None	Bivalirudin	Dead on ECMO

CPB, cardiopulmonary bypass; ECMO, extracorporeal membrane oxygenation; OR, operating room.